BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17890461)

  • 1. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
    Roldán V; Marín F; García-Herola A; Lip GY
    Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
    Freestone B; Chong AY; Blann AD; Lip GY
    Thromb Res; 2006; 118(4):479-85. PubMed ID: 16318868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
    Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
    Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
    Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial (dys)function in lone atrial fibrillation.
    Polovina MM; Lip GY; Potpara TS
    Curr Pharm Des; 2015; 21(5):622-45. PubMed ID: 25175088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
    Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
    Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.
    Kornej J; Dinov B; Blann AD; Rolf S; Arya A; Schmidl J; Husser D; Hindricks G; Bollmann A; Lip GY
    PLoS One; 2014; 9(11):e111760. PubMed ID: 25390649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
    Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
    Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis.
    Watson T; Shantsila E; Blann A; Lip GY
    Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.